Annotated Medicine and Device Lists

Ranitidine

Injection 25 mg/mL (as hydrochloride) in 2-mL ampoule Injection Injection 10 mg/mL Injection 50 mg (hydrochloride)/2 mL Oral liquid 75 mg/5 mL (as hydrochloride) Tablet 150 mg (as hydrochloride) Tablet 150 mg Tablet 300mg (hydrochloride) Tablet 150-300 mg Tablet 300 mg Tablet 150 mg (hydrochloride)

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BA H2-receptor antagonists) excluding combinations.
PAHO Strategic Fund Medicine List	15.1. Antiulcer	No observations
Peru	17.1.2 Anti-Ulcers	No observations
Cuba	17.1.2 Antihistamínicos H2	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Colombia	06.5 Peptic Ulcers	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BA H2-receptor antagonists) excluding combinations.
PAHO Strategic Fund Medicine List	15.1. Antiulcer	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BA H2-receptor antagonists) excluding combinations.
PAHO Strategic Fund Medicine List	15.1. Antiulcer	No observations
Peru	17.1.2 Anti-Ulcers	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Chile	Essential and Prioritized Medications	No observations
Cuba	17.1.2 Antihistamínicos H2	No observations

This medicine is present in:

List	Section	Observation
Peru	17.1.2 Anti-Ulcers	No observations
Colombia	06.5 Peptic Ulcers	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Colombia	06.5 Peptic Ulcers	No observations

Information Resources: Ranitidine

Should adults with gastro-esophageal reflux be treated with H2-antagonists compared to proton pump inhibitors?
Gastro-esophageal reflux disease.